Q2 2025 iRhythm Technologies Inc Earnings Call Transcript

Jul 31, 2025 / 08:30PM GMT

Release Date Price: $138.97 (-1.99%)

Transcript 10-Q8-K

Key Points

Positve

iRhythm Technologies Inc (IRTC) reported strong second-quarter results with $186.7 million in revenue, representing more than 26% year-over-year growth.
The company achieved record new account openings and long-term continuous monitoring driven by innovative channel partnerships.
International markets showed continued strong demand, with significant progress in the United Kingdom, Europe, and Japan.
The partnership with Lucem Health aims to accelerate early detection of undiagnosed arrhythmias using AI-driven solutions.
iRhythm Technologies Inc (IRTC) expanded adjusted EBITDA margins by 500 basis points since Q2 of last year, demonstrating sustainable operating leverage.

Negative

The company continues to incur incremental legal and consulting fees related to FDA remediation efforts and DOJ subpoena activities.
There is a potential negative impact on gross margins from tariffs, estimated to be 20 to 40 basis points for the full year.
The company expects to be slightly free cash flow negative for full year 2025 due to inventory buildup and infrastructure investments.
The innovative channel partners' contribution to revenue is still in the early stages and not fully predictable.
The FDA warning letter and 483 observations are still pending resolution, with ongoing efforts to address these regulatory concerns.

Operator

Good afternoon. Thank you for attending today's iRhythm Technologies Inc. Q2 2025 earnings conference call. My name is Bethany, and I will be the moderator for today's call. (Operator Instructions)

I would now like to pass the conference over to our host, Stephanie Zhadkevich, Senior Director of Investor Relations. Please go ahead.

Stephanie Zhadkevich

iRhythm Technologies Inc - Senior Director of Investor Relations

Thank you all for participating in today's call. Earlier today, iRhythm released financial results for the second quarter ended June 30, 2025. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that are not statements of historical fact should be deemed to be forward-looking statements. These are based upon our current estimates and various assumptions and reflect

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.